Seoul: Samsung Biologics Co. on Wednesday reported its fourth-quarter net profit of 453.1 billion won (US$308.2 million), marking an increase of 74.1 percent from the previous year.

According to Yonhap News Agency, the company's operating profit for the October-December period reached 528.3 billion won, reflecting a 67.8 percent rise from the same period last year. Additionally, the company's sales saw a significant growth of 35.3 percent, totaling 1.28 trillion won.

However, it is noted that the operating profit was 4.4 percent below the average estimate from a survey conducted by Yonhap Infomax, the financial data firm associated with Yonhap News Agency. The survey did not provide an estimate for the net profit.